A federal bankruptcy judge approved the sale of ProCure on Thursday, despite objections by the losing bidder and doctors at the cancer treatment center, NewsOK.com reported. The final details of the sale were not available, but the initial bid by David Raubach's Oklahoma Proton Center LLC included more than $17.3 million in cash to take on the struggling business. ProCure faced financial uncertainty primarily because insurance companies often refused to pay for proton therapy, which is a different type of radiation treatment for cancer patients. Instead of using X-rays that pass through the body, hitting both sick and healthy tissue, ProCure and other proton therapy centers are able to target cancerous masses and limit a person's radiation exposure. Raubach confirmed the judge's ruling on Friday; a final order was not yet available on the court's website. After the sale is closed, Raubach and two partners will manage the Oklahoma City facility. The plan is to keep it open and begin taking new patients in early 2019. Read more.
Examine how current challenges facing the health care industry will lead to future opportunities. Don't miss ABI's “Disruption, Consolidation and Innovation in the Health Care Industry” Program scheduled for January 17 at Georgetown University Law Center. Register here.
